miR-182-5p is an oncomiR that is overexpressed in several cancer types; it has been reported to inhibit the expression of targets such as FOXF2 (Forkhead box F2) and MTSS1 (Metastasis suppressor-1). Here, MTSS1 is linked to cancer.